Oral Cavity Dysplasia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-25
Clinical Trial Update: A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Tozuleristide as a fluorescent tumor marking agent for imaging oral cavity squamous cell carcinoma and…